EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Long-Term Efficacy and Safety of Remibrutinib in Patients with Chronic Spontaneous Urticaria in the Phase 3 REMIX-1 and REMIX-2 Studies

Friday 31 May, 16:45 PM - 16:57 PM Valencia, Spain